Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:38 PM
Ignite Modification Date:
2025-12-24 @ 7:38 PM
NCT ID:
NCT06690203
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years of age
* Diagnosed of chronic lower respiratory tract disorder(such as : asthma, COPD, emphysema, chronic bronchitis, bronchiectasis, lung fibrosis) by pulmonologist
* Have symptom of chronic cough, cough with sputum after using of a maintenance respiratory medication and stable disease more than 3 months.
* Willing to be evaluated by a Traditional Chinese Physician whether use of NRICM102 is suitable.
* The patient can use NRICM102 therapy after Traditional Chinese Physician evaluate. Able to understand and sign an informed consent ( or have a legal representative who is able to do so)
Exclusion Criteria:
* Females who are breastfeeding or pregnant at screening.
* Life threatening (e.g. intensive care admission and/or use of mechanical ventilation) respiratory failure event in the past 3 months.
* Patients with gastrointestinal malabsorption or condition that might affect the absorption of NRICM102 in the opinion of investigator. (exp: Irritable bowel syndrome, acute gastritis, duodenal ulcer..).
* Acute exacerbation or unstable vital signs on screening stage.
* Patient who have malignancy and receiving chemotherapy/ target therapy at screening.
* Diagnosis of liver cirrhosis or active hepatitis infection.
* Patient having renal dysfunction with Creatinine Clearance Calculator (CCR) \< 30mL/min.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06690203
Study Brief:
Protocol Section:
NCT06690203